Top Markets
Coin of the day
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc.

THRX
Classement en actions #19949
Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on... Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that promote cancer. Founded in 2017, the company operates out of Cambridge, Massachusetts.
Prix de l'action
$4.06
Dernière synchronisation: 2024-02-23
Capitalisation boursière
$145.61M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Theseus Pharmaceuticals, Inc. (THRX)

Catégorie

Historique du prix de l'action pour Theseus Pharmaceuticals, Inc. (THRX)
Prix de clôture le plus élevé : $4.07 le 2024-02-01

Prix de clôture le plus bas : $16.20 le 2021-10-01
Historique du prix de l'action de Theseus Pharmaceuticals, Inc. de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 5.46%
2023 -30.80%
2022 -54.19%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH